ResearchAndMarkets.com added two separate market studies to its offering: a biochip report forecasting growth from USD 7.66 billion in 2025 to USD 29.31 billion by 2035, and a bionic devices report projecting expansion from $7.17 billion in 2025 to $14.9 billion by 2034. The biochip outlook cites rapid diagnostics, personalized medicine, microarrays, microfluidics, point-of-care testing and high-throughput analysis, while the bionic devices study cites artificial intelligence, robotics, neural interfaces, rehabilitation demand, aging populations and chronic disease. The reports also identify barriers including regulatory requirements, costs, reimbursement limitations, infrastructure gaps and technical constraints.